Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MedMira Inc MMIRF


Primary Symbol: V.MIR

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.


TSXV:MIR - Post by User

Post by august202013on Aug 30, 2023 10:13am
165 Views
Post# 35611740

CFO MM MUST ADDRESS ISSUE IMMEDIATELLY

CFO MM MUST ADDRESS ISSUE IMMEDIATELLYMIR CFO MM MUST PUT ACT TOGETHER IMMEDIATELLY TO RESOLVED THE ISSUE WITH THE SECURITIES COMMISSION THEN MAKE A PRESS RELEASE 

HC MIR CANNOT AFFORD TO DILLY DALLY ANYMORE THE LONGER BEING PROLONGED THE MORE POTENTIAL DAMAGE. TOO MUCH IS AT STAKE AS MIGHT DISRUPT FUTURE BUSINESSES.

HAVE TO PERFECTED ALL ONESELVES AND THEN DO A FULL AUDIT TO REVIEW ALL COMPLIANCE MOVING FORWARD TO AVOID ANOTHER FALLOUT.

NO CHOICE BUT HAVE TO FOLLOW MRMARKET
TO LEAVE MIR IN A WILL.

<< Previous
Bullboard Posts
Next >>